{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "High-content imaging",
      "Vaccinia",
      "Virus plaque assay",
      "Virus spread"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "31240682",
  "DateCompleted": {
    "Year": "2020",
    "Month": "03",
    "Day": "30"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "03",
    "Day": "17"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1007/978-1-4939-9593-6_15"
    ],
    "Journal": {
      "ISSN": "1940-6029",
      "JournalIssue": {
        "Volume": "2023",
        "PubDate": {
          "Year": "2019"
        }
      },
      "Title": "Methods in molecular biology (Clifton, N.J.)",
      "ISOAbbreviation": "Methods Mol Biol"
    },
    "ArticleTitle": "High-Content Analyses of Vaccinia Plaque Formation.",
    "Pagination": {
      "StartPage": "237",
      "EndPage": "253",
      "MedlinePgn": "237-253"
    },
    "Abstract": {
      "AbstractText": [
        "Vaccinia virus plaque assays are employed for quantification of virus titer through serial dilution of virus on a monolayer of cells. Once the virus titer is diluted enough to allow for only few cells of the monolayer to be infected, clonal spread of infection can be detected by observing the lesion in the cell monolayer or using virus-specific staining methods. Beyond simple titration, plaque formation bares priceless underlying information about subtle virus-host interactions and their impact on virus spread during multiple rounds of infection. These include virus infectivity, mode of virus spread, virus replication rate, and spatiotemporal spread efficacy. How this underlying information can be harnessed using a high-content imaging setup is discussed here."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "MRC-Laboratory for Molecular Cell Biology, University College London, London, UK. a.yakimovich@ucl.ac.uk."
          }
        ],
        "LastName": "Yakimovich",
        "ForeName": "Artur",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "MRC-Laboratory for Molecular Cell Biology, University College London, London, UK. jason.mercer@ucl.ac.uk."
          }
        ],
        "LastName": "Mercer",
        "ForeName": "Jason",
        "Initials": "J"
      }
    ],
    "GrantList": [
      {
        "GrantID": "MC_UU_12018/7",
        "Acronym": "MRC_",
        "Agency": "Medical Research Council",
        "Country": "United Kingdom"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Methods Mol Biol",
    "NlmUniqueID": "9214969",
    "ISSNLinking": "1064-3745"
  },
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Animals"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Cell Line"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "virology"
      ],
      "DescriptorName": "Vaccinia"
    },
    {
      "QualifierName": [
        "pathogenicity"
      ],
      "DescriptorName": "Vaccinia virus"
    },
    {
      "QualifierName": [
        "methods"
      ],
      "DescriptorName": "Viral Plaque Assay"
    },
    {
      "QualifierName": [
        "physiology"
      ],
      "DescriptorName": "Virus Replication"
    }
  ]
}